lung-neoplasms

Documents about lung-neoplasms

• Korea Post Marketing Surveillance (PMS) Study of Vizimpro#1007760ClinicalTrials.gov
• Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)#914517ClinicalTrials.gov
• Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer#902725ClinicalTrials.gov
• A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.#886504ClinicalTrials.gov
• Family-centred Pulmonary Rehabilitation to Empower Carers#831279ClinicalTrials.gov
• Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer#835150ClinicalTrials.gov
• Chest Imaging of Lung Nodule(s) Under High-frequency Non-invasive Ventilation (HF-NIV)#991850ClinicalTrials.gov
• TELESCOPE- TELEhealth Shared Decision-making COaching#991984ClinicalTrials.gov
• Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer)#201620ClinicalTrials.gov
• Type I interferons induced upon respiratory viral infection impair lung metastatic initiation#466372Spiral
• Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer#913857ClinicalTrials.gov
• Integrated machine learning risk model for predicting radiation pneumonitis in lung cancer patients with interstitial lung disease.#9709PubMed
• Treatment of Multifocal Lung Adenocarcinoma#875833ClinicalTrials.gov
• A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer#897366ClinicalTrials.gov
• Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma#838994ClinicalTrials.gov
• Association of Psychological Distress in Patients With Lung Cancer#363624ClinicalTrials.gov
• ALG-LungCancerRegistry (SAFRO2202)#414484ClinicalTrials.gov
• TR(ACE) Assay Clinical Specimen Study#800548ClinicalTrials.gov
• A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers#842351ClinicalTrials.gov
• Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54#801923ClinicalTrials.gov
• LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung#888401ClinicalTrials.gov
• A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors#405118ClinicalTrials.gov
• Application of 4DCT-Based Pulmonary Ventilation Imaging in Lung Cancer Radiotherapy#897564ClinicalTrials.gov
• Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer#897212ClinicalTrials.gov
• Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)#417556ClinicalTrials.gov
• A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer#903046ClinicalTrials.gov
• Navigated EBUS and Functional Imaging in Lung Cancer#898322ClinicalTrials.gov
• 3D Virtual Resection for Predicting Lung Function in VATS#858184ClinicalTrials.gov
• Lung Cancer Screening With Low-dose CT Scan in Women : Implementation Study#840444ClinicalTrials.gov
• A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors#901841ClinicalTrials.gov
• Women's Health Initiative (WHI)#835330ClinicalTrials.gov
• Evaluation of a Scalable Decision Support and Shared Decision Making Tool for Lung Cancer Screening#896849ClinicalTrials.gov
• Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer#838319ClinicalTrials.gov
• Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung Adenocarcinoma#877770ClinicalTrials.gov
• Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer#1007865ClinicalTrials.gov
• Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer#868809ClinicalTrials.gov
• A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer.#646483PubMed
• Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer#803197ClinicalTrials.gov
• Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)#846136ClinicalTrials.gov
• Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After Previous Chemotherapy and Surgical Removal of the NSCLC Tumor#890293ClinicalTrials.gov
• Construction and Preliminary Evaluation of Dyadic Acceptance and Commitment Therapy for Couples With Fear of Lung Cancer Recurrence#892289ClinicalTrials.gov
• Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer#981790ClinicalTrials.gov
• An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed#1008652ClinicalTrials.gov
• Safety Study of SEA-CD40 in Cancer Patients#837685ClinicalTrials.gov
• Enhanced COPD Management in Suspected Lung Cancer Patients#851253ClinicalTrials.gov
• Nitride-Based Raman Biochip for Lung Cancer Diagnosis and Monitoring#874760ClinicalTrials.gov
• Critical requirement of SOS1 for tumor development and microenvironment modulation in KRASG12D-driven lung adenocarcinoma#294496Gestión del Repositorio Documental de la Universidad de Salamanca
• Local Anesthesia Versus Combined Local Anesthesia With Single Dose Analgesia on Pain Control During Thoracic Ultrasound Guided Procedures#826629ClinicalTrials.gov
• Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients#842297ClinicalTrials.gov
• Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer#898458ClinicalTrials.gov